Trials / Active Not Recruiting
Active Not RecruitingNCT05939128
A Non-interventional Prospective Study of Early HER2-negative High-risk Breast Cancer and BRCA1/2 Mutations Prevalence in RussiA
A Multicentre, Single Arm, Non-interventional, Observational, Prospective Study to Assess the BRCA1/2m Prevalence, Treatment Approaches and Outcomes in HER2-negative High-risk Early Breast Cancer Patients in Russia
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 625 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
(Neo)adjuvant treatment approaches and outcomes
Conditions
Timeline
- Start date
- 2023-06-30
- Primary completion
- 2027-09-30
- Completion
- 2027-09-30
- First posted
- 2023-07-11
- Last updated
- 2026-02-12
Locations
19 sites across 1 country: Russia
Source: ClinicalTrials.gov record NCT05939128. Inclusion in this directory is not an endorsement.